Methylphenidate Controlled-Release Tablets and Siltuximab Intravenous
Determining the interaction of Methylphenidate Controlled-Release Tablets and Siltuximab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: methylphenidate
Brand name: Adhansia XR, Aptensio XR, Concerta, Cotempla XR-ODT, Jornay PM, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Relexxii, Ritalin, Ritalin LA, Ritalin SR, Daytrana, Methylin ER
Synonyms: Methylphenidate
Generic Name: siltuximab
Brand name: Sylvant
Synonyms: Siltuximab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Methylphenidate Controlled-Release Tablets-Silvadene
- Methylphenidate Controlled-Release Tablets-Silvadene Topical
- Methylphenidate Controlled-Release Tablets-SilvaSorb
- Methylphenidate Controlled-Release Tablets-Silver
- Methylphenidate Controlled-Release Tablets-Silver Nitrate
- Methylphenidate Controlled-Release Tablets-Silver Nitrate Applicators
- Siltuximab Intravenous-Methylphenidate ER Capsules
- Siltuximab Intravenous-Methylphenidate Extended-Release Capsules (Evening Formulation)
- Siltuximab Intravenous-Methylphenidate Extended-Release Chewable Tablets
- Siltuximab Intravenous-Methylphenidate Extended-Release Oral Suspension
- Siltuximab Intravenous-Methylphenidate Extended-Release Oral-Disintegrating Tablets
- Siltuximab Intravenous-Methylphenidate Extended-Release Tablets